Study: Sleep disturbances with combo
Question:
In article <Ocu45.1208$mG6.9…@typhoon.columbus.rr.com>, cmhda…@columbus.rr.com (cmhDavid) wrote: > They needed a study to prove this? Hell, anyone who has HCV has sleep > disturbances! With or with out the combo! > David
ROFL! Alan
Response:
In article <G2r45.214225$MB.3881…@news6.giganews.com>, "SuzMc" <smccl…@ibnetwork.org> wrote: > I take ambien. I definitely SLEEP!
I take Benadryal which also helps my runny nose from the combo. I just have to limit myself to Benadryl only 2 or 3 times a week. My doctor said that taking Benadryl steadily over a period of time causes depression – which you definitely don’t need on combo. ; ) — The Big Kat (Kathy M.) Hepatitis Links http://www.zeal.com/Personal/Health/Diseases___Conditions/Liver_Disea… Sent via Deja.com http://www.deja.com/ Before you buy.
Response:
They needed a study to prove this? Hell, anyone who has HCV has sleep disturbances! With or with out the combo! David — http://members.aol.com/cmhdavid The Big Kat at Petsnpeople <petsnpeo…@webtv.net> wrote in message news:8it7m8$3v4$1@nnrp1.deja.com… – Hide quoted text — Show quoted text -> DG DISPATCH – APSS: Sleep Disturbances Found In Patients Taking Common > Hepatitis C Treatment > LAS VEGAS, NV — June 19, 2000 — Daytime sleepiness and disturbed nocturnal > sleep are common in patients with chronic hepatitis C treated with > concomitant interferon alpha-2b plus ribavirin, according to data presented > at the 14th Annual Meeting of the Associated Professional Sleep Societies. > Dr. Cinda H. Clark and associates at the University of Texas Medical School > in Houston used the Epworth Sleepiness Scale (ESS) and the Sleep Quality > Profile (SQP) to determine the frequency of sleep disturbances in 57 patients > who had been receiving interferon alpha-2b plus ribavirin for five to six > months for chronic hepatitis C. The ESS measures daytime sleepiness, and the > SQP measures symptoms of nocturnal sleep disturbances. > All subjects had compensated liver disease but no concomitant uncontrolled > illnesses. None was HIV-positive. > While various studies have reported insomnia in 20 to 39 percent of patients > receiving interferon alpha-2b plus ribavirin therapy for chronic hepatitis C, > the investigations did not quantify or characterize the nature of the > reported insomnia, Dr. Clark said. > Results showed that the mean ESS score was 9.6, and 22 (54 percent) patients > had scores greater than 10, indicating daytime sleepiness. Six (15 percent) > had an ESS score greater than 16, indicating extreme daytime sleepiness. Of > patients with an ESS score less than 10, symptoms of insomnia predominated. > The mean SQP score was 4.7. Twenty-seven (66 percent) patients reported at > least three symptoms of disturbed sleep. In addition, 77.5 percent were tired > and unrefreshed when they woke up, 75 percent had restless sleep, and 72.5 > percent reported arm or leg movements during sleep. > The data also showed that 55 percent of patients snored, 57.5 percent had > difficulty sleeping at night, 20 percent woke up gasping or choking during > the night and ten percent had witnessed apneas. > Dr. Clark added that further studies using polysomnography and multiple > latency sleep testing are needed to confirm and characterize these sleep > disturbances > — > The Big Kat (Kathy M.) > Hepatitis Links
http://www.zeal.com/Personal/Health/Diseases___Conditions/Liver_Disea… atitis/ – Hide quoted text — Show quoted text -> Sent via Deja.com http://www.deja.com/ > Before you buy.
Response:
I take ambien. I definitely SLEEP! The Big Kat at Petsnpeople <petsnpeo…@webtv.net> wrote in message news:8it7m8$3v4$1@nnrp1.deja.com… – Hide quoted text — Show quoted text -> DG DISPATCH – APSS: Sleep Disturbances Found In Patients Taking Common > Hepatitis C Treatment > LAS VEGAS, NV — June 19, 2000 — Daytime sleepiness and disturbed nocturnal > sleep are common in patients with chronic hepatitis C treated with > concomitant interferon alpha-2b plus ribavirin, according to data presented > at the 14th Annual Meeting of the Associated Professional Sleep Societies. > Dr. Cinda H. Clark and associates at the University of Texas Medical School > in Houston used the Epworth Sleepiness Scale (ESS) and the Sleep Quality > Profile (SQP) to determine the frequency of sleep disturbances in 57 patients > who had been receiving interferon alpha-2b plus ribavirin for five to six > months for chronic hepatitis C. The ESS measures daytime sleepiness, and the > SQP measures symptoms of nocturnal sleep disturbances. > All subjects had compensated liver disease but no concomitant uncontrolled > illnesses. None was HIV-positive. > While various studies have reported insomnia in 20 to 39 percent of patients > receiving interferon alpha-2b plus ribavirin therapy for chronic hepatitis C, > the investigations did not quantify or characterize the nature of the > reported insomnia, Dr. Clark said. > Results showed that the mean ESS score was 9.6, and 22 (54 percent) patients > had scores greater than 10, indicating daytime sleepiness. Six (15 percent) > had an ESS score greater than 16, indicating extreme daytime sleepiness. Of > patients with an ESS score less than 10, symptoms of insomnia predominated. > The mean SQP score was 4.7. Twenty-seven (66 percent) patients reported at > least three symptoms of disturbed sleep. In addition, 77.5 percent were tired > and unrefreshed when they woke up, 75 percent had restless sleep, and 72.5 > percent reported arm or leg movements during sleep. > The data also showed that 55 percent of patients snored, 57.5 percent had > difficulty sleeping at night, 20 percent woke up gasping or choking during > the night and ten percent had witnessed apneas. > Dr. Clark added that further studies using polysomnography and multiple > latency sleep testing are needed to confirm and characterize these sleep > disturbances > — > The Big Kat (Kathy M.) > Hepatitis Links
http://www.zeal.com/Personal/Health/Diseases___Conditions/Liver_Disea… atitis/ – Hide quoted text — Show quoted text -> Sent via Deja.com http://www.deja.com/ > Before you buy.
Response:
DG DISPATCH – APSS: Sleep Disturbances Found In Patients Taking Common Hepatitis C Treatment LAS VEGAS, NV — June 19, 2000 — Daytime sleepiness and disturbed nocturnal sleep are common in patients with chronic hepatitis C treated with concomitant interferon alpha-2b plus ribavirin, according to data presented at the 14th Annual Meeting of the Associated Professional Sleep Societies. Dr. Cinda H. Clark and associates at the University of Texas Medical School in Houston used the Epworth Sleepiness Scale (ESS) and the Sleep Quality Profile (SQP) to determine the frequency of sleep disturbances in 57 patients who had been receiving interferon alpha-2b plus ribavirin for five to six months for chronic hepatitis C. The ESS measures daytime sleepiness, and the SQP measures symptoms of nocturnal sleep disturbances. All subjects had compensated liver disease but no concomitant uncontrolled illnesses. None was HIV-positive. While various studies have reported insomnia in 20 to 39 percent of patients receiving interferon alpha-2b plus ribavirin therapy for chronic hepatitis C, the investigations did not quantify or characterize the nature of the reported insomnia, Dr. Clark said. Results showed that the mean ESS score was 9.6, and 22 (54 percent) patients had scores greater than 10, indicating daytime sleepiness. Six (15 percent) had an ESS score greater than 16, indicating extreme daytime sleepiness. Of patients with an ESS score less than 10, symptoms of insomnia predominated. The mean SQP score was 4.7. Twenty-seven (66 percent) patients reported at least three symptoms of disturbed sleep. In addition, 77.5 percent were tired and unrefreshed when they woke up, 75 percent had restless sleep, and 72.5 percent reported arm or leg movements during sleep. The data also showed that 55 percent of patients snored, 57.5 percent had difficulty sleeping at night, 20 percent woke up gasping or choking during the night and ten percent had witnessed apneas. Dr. Clark added that further studies using polysomnography and multiple latency sleep testing are needed to confirm and characterize these sleep disturbances — The Big Kat (Kathy M.) Hepatitis Links http://www.zeal.com/Personal/Health/Diseases___Conditions/Liver_Disea… Sent via Deja.com http://www.deja.com/ Before you buy.
